Category: Vaccines
Global Vaccines
-
Celiac Disease Drugs Market by Drug (First Line of Treatment, Second Line of Treatment), Type (Steroids & Immunosuppressive Drugs, Therapeutic Vaccines, Vitamins & Dietary Supplements), Indication, End-User - Global Forecast 2024-2030
... Market size was estimated at USD 1.42 billion in 2023 and expected to reach USD 1.56 billion in 2024, at a CAGR 10.59% to reach USD 2.87 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Neglected Tropical Disease Treatment Market by Product (Drugs, Vaccines), Types of Diseases (Buruli Ulcer, Chagas Disease, Dengue), Diagnostic Method - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 6.40 billion in 2024, at a CAGR 6.25% to reach USD 9.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Global Forecast 2024-2030
... 37.59 billion in 2023 and expected to reach USD 42.91 billion in 2024, at a CAGR 14.63% to reach USD 97.79 billion by 2030. Global Veterinary Pharmaceuticals Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Global Forecast 2024-2030
... 354.89 million in 2023 and expected to reach USD 372.64 million in 2024, at a CAGR 4.82% to reach USD 493.67 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Global Microcarriers MarketMicrocarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide ... Read More
-
2024 Global: Vaccines Against Sars-Related Coronaviruses "Sars-Cov Species", For Human Medicine Products-Manufacturing Forecast (2030) report
... projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and ... Read More
-
Cancer Vaccines Market by Technology (Antigen, Dendritic Cells, Recombinant Cancer Vaccines), Treatment Method (Preventive Vaccine, Therapeutic Vaccine), Application - Global Forecast 2024-2030
... and expected to reach USD 20.56 billion in 2024, at a CAGR 15.37% to reach USD 48.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cancer Vaccines Market. ... Read More
-
Vaccine Adjuvants Market by Product (Adjuvant Emulsions, Combination Adjuvants, Mineral Adjuvants), Route of Administration (Intradermal, Intramuscular, Intranasal), Disease, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 884.18 million in 2024, at a CAGR 7.88% to reach USD 1,404.20 million by 2030. Global Vaccine Adjuvants Market Vaccine adjuvants are essential components in the formulation of vaccines, ... Read More
-
Cancer Biological Therapy Market by Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), Route of Administration (Intramuscular, Intravenous, Subcutaneous), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 72.42 billion in 2024, at a CAGR 11.60% to reach USD 140.04 billion by 2030. Global Cancer Biological Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Malaria Vaccine Market by Type (Erythrocytic Vaccine, Multi-Antigen Vaccine, Pre-Erythrocytic Vaccine), Agent (Anopheles Species, Plasmodium Falciparum, Plasmodium Vivax), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 80.88 million in 2024, at a CAGR 25.78% to reach USD 320.66 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Malaria Vaccine ... Read More
-
Virus Filtration Market by Product (Filtration Systems, Kits & Reagents), Application (Air Purification, Biologicals, Medical Devices), End User - Global Forecast 2024-2030
... and expected to reach USD 2.49 billion in 2024, at a CAGR 14.35% to reach USD 5.60 billion by 2030. Global Virus Filtration Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Global Forecast 2024-2030
... 2023 and expected to reach USD 943.11 million in 2024, at a CAGR 39.62% to reach USD 7,011.84 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the HIV Vaccines ... Read More
-
Biopharmaceutical Processing Equipment & Consumables Market by Product (Bioprocessing Containers, Bioreactors, Biosafety Cabinets), Application (Monoclonal Antibody, Vaccine), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 51.25 billion in 2024, at a CAGR 9.07% to reach USD 86.18 billion by 2030. Global Biopharmaceutical Processing Equipment & Consumables Market FPNV Positioning Matrix The FPNV ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Market by Cancer Type (Breast, Colorectal, Head and Neck), Drug Type (Immunomodulators, Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines), Service Type - Global Forecast 2024-2030
... Discovery Outsourcing Market size was estimated at USD 1.60 billion in 2023 and expected to reach USD 1.84 billion in 2024, at a CAGR 15.59% to reach USD 4.41 billion by 2030. Global Cancer Immunotherapy ... Read More
-
COVID-19 Vaccines Market by Product Type (Monovalent Vaccine, Multivalent Vaccine), End-User (Academic & Research Centers, Clinics, Hospitals), Patient Type - Global Forecast 2024-2030
... 2023 and expected to reach USD 237.12 billion in 2024, at a CAGR 10.55% to reach USD 434.83 billion by 2030. Global COVID-19 Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Cancer Immunotherapy Drugs Market by Type (Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), Indication (Breast Cancer, Colorectal Cancer, Head & Neck Cancer), End-user - Global Forecast 2024-2030
... 215.29 billion in 2023 and expected to reach USD 243.31 billion in 2024, at a CAGR 13.10% to reach USD 509.93 billion by 2030. Global Cancer Immunotherapy Drugs Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Conjugate Vaccine Market by Type (Monovalent, Multivalent), Indication (Diphtheria & Pertussis, Influenza, Meningococcal), Pathogen Type, End-User - Global Forecast 2024-2030
... to reach USD 43.92 billion in 2024, at a CAGR 10.81% to reach USD 81.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Conjugate Vaccine Market. It offers ... Read More
-
Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-
... The Allergy Vaccine Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 11.51% to reach USD 2.75 billion by 2030. FPNV Positioning ... Read More
-
Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers ... Read More
-
Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adolescent Vaccination, Adult Vaccination, Infant Vaccination), Administration Route, Distribution Channel - Global Forecast 2024-2030
... 7.92 billion in 2023 and expected to reach USD 8.61 billion in 2024, at a CAGR 9.01% to reach USD 14.49 billion by 2030. Global Influenza Vaccine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Therapeutic BCG Vaccines Global Market Report 2024
... National Biotec Group; Serum Institute of India Pvt. Ltd. Therapeutic BCG Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess ... Read More
-
Global Cell Culture Media for Vaccine Market Growth 2025-2031
... is expected to grow at a CAGR of 7.9% from 2025 to 2031. Cell Culture Media are used to provide nutrients for cells growth in research, diagnostic and manufacturing applications. Typical cell culture media contain ... Read More
-
Adult Vaccines Global Market Report 2024
... Zoster; Pneumococcal; Hepatitis4) By End Users: Healthcare Firms; HospitalsCovering: GlaxoSmithKline PLC; Merck & Co; Sanofi Pasteur; Pfizer Inc; Commonwealth Serum Laboratories Limited Adult Vaccines Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024(Status and Outlook)
... in 2023 and is projected to reach USD 1161.93 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Hepatitis B Vaccines market covering ... Read More
Research Assistance
